Mersana Therapeutics Inc. (NASDAQ:MRSN) released initial data from the Phase 1 dose escalation and backfill cohorts for ...
Analyst Charles Zhu from LifeSci Capital maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report) and keeping the price target ...
Mersana Therapeutics (MRSN) stock hits a 52-week low in reaction to early clinical results for its cancer drug Emi-Le in ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
NDAQ:MRSN) Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660) ...
Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug ...
Announces Positive Initial Clinical Data for Emi-Le in Cancer Treatment ...
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Avi Kapoor Why Butterfly Network Shares Are Trading Lower By 22%? Here Are ...
Orphan Drug Tag For Mersana's Gastric Cancer Candidate Vandana Singh Mersana Therapeutics Director Andrew Hack Reported Purchase of 350,000 Shares @ Avg Price of $3.25/Share in Form 4 Filing on ...
Mercedes-Benz experienced a decline in core car sales throughout 2024, reflecting a challenging year for the auto industry, ...
U.S. President-elect Donald Trump will not go to jail or face any other punishment for his criminal conviction stemming from hush money paid to a porn star, a judge ruled on Friday but said Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback